Published in Ann Surg Oncol on October 10, 2007
Chemotherapy with laparoscope-assisted continuous circulatory hyperthermic intraperitoneal perfusion for malignant ascites. World J Gastroenterol (2010) 1.12
Laparoscopic mucin removal in patients with pseudomyxoma peritonei. JSLS (2009) 0.94
Multivariate comparison of B-ultrasound guided and laparoscopic continuous circulatory hyperthermic intraperitoneal perfusion chemotherapy for malignant ascites. Surg Endosc (2013) 0.84
Evaluation of oxaliplatin exposure of healthcare workers during heated intraperitoneal perioperative chemotherapy (HIPEC). Ind Health (2014) 0.83
Peritoneal carcinomatosis: intraoperative parameters in open (coliseum) versus closed abdomen HIPEC. Int J Surg Oncol (2015) 0.79
Different sequential approaches of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treating ovarian cancer with malignant ascites. J Cancer Res Clin Oncol (2014) 0.79
Surgical technology and pharmacology of hyperthermic perioperative chemotherapy. J Gastrointest Oncol (2016) 0.76
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol (2003) 7.57
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol (2004) 4.15
Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol (1999) 2.02
Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals, based on registered information of outcome. J Epidemiol Community Health (1985) 1.94
A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. N Engl J Med (1985) 1.83
Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin C. Ann Surg Oncol (2002) 1.68
Mutagenicity in urine of nurses handling cytostatic drugs. Lancet (1979) 1.58
Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol (2002) 1.55
High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg (2006) 1.22
Risk of spontaneous abortion among nurses handling antineoplastic drugs. Scand J Work Environ Health (1990) 1.12
Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study. World J Surg (1994) 0.99
Allergy to the complex salts of platinum. A review of the literature and three case reports. Scand J Work Environ Health (1982) 0.96
Technology of intraperitoneal chemotherapy administration: a survey of techniques with a review of morbidity and mortality. Surg Oncol Clin N Am (2003) 0.88
Investigations on safety of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with Mitomycin C. Eur J Surg Oncol (2006) 0.87
Mutagenicity of urine from nurses handling cytostatic drugs, influence of smoking. Int Arch Occup Environ Health (1982) 0.86
Occupational handling of cytostatic drugs. Arch Toxicol (1983) 0.85
Mutagenicity in urine from nurses handling cytostatic agents. Eur J Cancer Clin Oncol (1986) 0.84
Determination of the vaporization of solutions of mutagenic antineoplastic agents at 23 and 37 degrees C using a desiccator technique. Mutat Res (2000) 0.84
Hyperthermic intraoperative intraperitoneal chemotherapy safety considerations. AORN J (1996) 0.81
[Treatment of peritoneal carcinomatosis using complete excision and intraperitoneal chemohyperthermia. A phase I-II study defining the best technical procedures]. Chirurgie (1999) 0.81
Monitoring for hazardous drugs in the operating room. Ann Surg Oncol (2003) 0.80
[Intraperitoneal chemo-hyperthermia with "overflow" open abdomen]. Ann Chir (2001) 0.79
[Cost of an intraperitoneal chemohyperthermia (IPCH) related to cytoreductive surgery]. Ann Chir (2005) 0.78
Permeability of nitrile rubber, latex, polyurethane, and neoprene gloves to 18 antineoplastic drugs. Am J Health Syst Pharm (1999) 0.78
The approval process for hyperthermic intraoperative intraperitoneal chemotherapy. Eur J Surg Oncol (2006) 0.78
Urine mutagenicity, chromosomal abnormalities and sister chromatid exchanges in lymphocytes of nurses handling cytostatic drugs. Int Arch Occup Environ Health (1986) 0.78
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med (2011) 24.32
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. Eur J Immunol (2004) 5.02
Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients. Cancer Immunol Immunother (2006) 4.48
Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J Exp Med (2005) 3.64
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest (2010) 2.89
Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Res (2008) 2.83
Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers. Int J Cancer (2008) 2.68
Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells. Clin Cancer Res (2008) 1.82
Diagnostic accuracy of C-reactive protein and white blood cell counts in the early detection of infectious complications after colorectal surgery. Int J Colorectal Dis (2011) 1.77
Arterial embolotherapy for endoscopically unmanageable acute gastroduodenal hemorrhage: predictors of early rebleeding. Clin Gastroenterol Hepatol (2009) 1.69
A spontaneous rupture of the external iliac vein revealed as a phlegmasia cerulea dolens with acute lower limb ischemia: Case report and review of the literature. J Vasc Surg (2002) 1.65
Population pharmacokinetics and dosing recommendations for cisplatin during intraperitoneal peroperative administration: development of a limited sampling strategy for toxicity risk assessment. Clin Pharmacokinet (2009) 1.44
Trends in incidence and management of esophageal adenocarcinoma in a well-defined population. Gastroenterol Clin Biol (2005) 1.40
Tumor cells can escape DNA-damaging cisplatin through DNA endoreduplication and reversible polyploidy. Cell Biol Int (2008) 1.38
Psychiatric drug-induced fatal abdominal compartment syndrome. Am J Emerg Med (2011) 1.38
Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy. Breast Cancer Res Treat (2010) 1.31
C-reactive protein is an early predictor of septic complications after elective colorectal surgery. World J Surg (2010) 1.24
Transcatheter arterial embolization of splenic artery aneurysms and pseudoaneurysms: short- and long-term results. Ann Vasc Surg (2008) 1.23
High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg (2006) 1.22
Refractory bleeding from gastroduodenal ulcers: arterial embolization in high-operative-risk patients. J Clin Gastroenterol (2008) 1.16
A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix. Ann Surg (2010) 1.16
Short- and long-term results of transcatheter embolization for massive arterial hemorrhage from gastroduodenal ulcers not controlled by endoscopic hemostasis. Can J Gastroenterol (2009) 1.13
Immunologic effects of rituximab on the human spleen in immune thrombocytopenia. Blood (2011) 1.09
EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib. Int J Cancer (2012) 1.07
About the Rationale for Heating Oxaliplatin During HIPEC. Ann Surg (2016) 1.05
CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer. J Clin Invest (2008) 1.01
Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib. Int J Cancer (2013) 0.97
Which method to deliver hyperthermic intraperitoneal chemotherapy with oxaliplatin? An experimental comparison of open and closed techniques. Ann Surg Oncol (2010) 0.95
Evaluation of pelvic posterior exenteration in the management of advanced-stage ovarian cancer. Arch Gynecol Obstet (2009) 0.95
Relation between bevacizumab dose intensity and high-grade glioma survival: a retrospective study in two large cohorts. J Neurooncol (2011) 0.95
High pressure enhances the effect of hyperthermia in intraperitoneal chemotherapy with oxaliplatin: an experimental study. Ann Surg (2012) 0.94
Diagnostic Accuracy of Inflammatory Markers As Early Predictors of Infection After Elective Colorectal Surgery: Results From the IMACORS Study. Ann Surg (2016) 0.94
Screening of anticancer drugs for chemoembolization of hepatocellular carcinoma. Anticancer Drugs (2011) 0.91
Serum and intraperitoneal pharmacokinetics of cisplatin within intraoperative intraperitoneal chemotherapy: influence of protein binding. Anticancer Drugs (2005) 0.90
Preventing lymphedema and morbidity with an omentum flap after ilioinguinal lymph node dissection. Ann Surg Oncol (2005) 0.89
Influcence of localization of primary tumor on effectiveness of 5-fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) in patients with metastatic pancreatic adenocarcinoma: a retrospective study. Anticancer Res (2012) 0.88
Nucleoside-lipid-based nanoparticles for cisplatin delivery. ACS Nano (2011) 0.86
Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins. Cancer Chemother Pharmacol (2002) 0.86
Phase 2 study of intratumoral cisplatin and epinephrine treatment for locally recurrent head and neck tumors. Ann Otol Rhinol Laryngol (2004) 0.84
Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 Phase I trial. Int J Radiat Oncol Biol Phys (2010) 0.84
The short- and long-term outcomes of pancreaticoduodenectomy for cancer in Child A patients are acceptable: a patient-control study from the Surgical French Association report for pancreatic surgery. J Surg Oncol (2015) 0.84
Multiple duodenal stromal tumors revealing type 1 neurofibromatosis: an indication for pancreas-preserving duodenectomy. Surgery (2012) 0.83
Childbearing after hyperthermic intraperitoneal chemotherapy: results from an international survey. Ann Surg Oncol (2011) 0.83
Rationale supporting the use of vasoconstrictors for intraperitoneal chemotherapy with platinum derivatives. Surg Oncol Clin N Am (2003) 0.83
Diagnostic Accuracy of Procalcitonin and C-reactive Protein for the Early Diagnosis of Intra-abdominal Infection After Elective Colorectal Surgery: A Meta-analysis. Ann Surg (2016) 0.82
Hypoxic single-pass isolated hepatic perfusion of hypotonic Cisplatin: safety study in the pig. Ann Surg Oncol (2009) 0.82
Bevacizumab efficacy in metastatic colorectal cancer is dependent on primary tumor resection. Ann Surg Oncol (2014) 0.82
CT-scan imaging of iron marked chorda tympani nerve: anatomical study and educational perspectives. Surg Radiol Anat (2011) 0.82
Discrepancy between in vitro and in vivo antitumor effect of a new platinum(II) metallointercalator. Invest New Drugs (2010) 0.82
Low urine osmolarity as a determinant of cisplatin-induced nephrotoxicity. Int J Cancer (2004) 0.82
Incidence and survival in late liver metastases of colorectal cancer. J Gastroenterol Hepatol (2015) 0.81
Heterogeneous sensitivity of hepatocellular carcinoma to sorafenib revealed by the short-term culture of tumor fragments. Anticancer Res (2013) 0.81
Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer. World J Surg Oncol (2009) 0.81
Direct intratumoral chemotherapy with carboplatin and epinephrine in a recurrent cervical chordoma: case report. Neurosurgery (2009) 0.81
3' Mutation of the APC gene and family history of FAP in a patient with apparently sporadic desmoid tumors. J Clin Gastroenterol (2007) 0.81
Comparison of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a murine model of peritoneal carcinomatosis. J Exp Clin Cancer Res (2011) 0.81
Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer. Cancer Chemother Pharmacol (2007) 0.81
[Stercoral perforation of the colon. Physiopathology and treatment strategy]. Gastroenterol Clin Biol (2007) 0.80
Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis. Anticancer Drugs (2006) 0.80
Preferential splenic CD8(+) T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia. Blood (2013) 0.80
Pneumatosis intestinalis and pneumoperitoneum during treatment by paclitaxel. Surgery (2009) 0.80
Intraoperative chemotherapy with cisplatin and epinephrine after cytoreductive surgery in patients with recurrent ovarian cancer: a phase I study. Anticancer Drugs (2010) 0.80
Prolonged administration of adjuvant temozolomide improves survival in adult patients with glioblastoma. Anticancer Res (2013) 0.79
Spatial relationships between lingual nerve and mandibular ramus: original study method, clinical and educational applications. Surg Radiol Anat (2009) 0.79
Prevention of peritoneal carcinomatosis from colon cancer cell seeding using a pirarubicin solution in rats and nude mice. World J Surg (2004) 0.79
Perforation of bowel lymphoma: beware of atypical presentations. J Gastrointest Cancer (2014) 0.78
cis-Dichloroplatinum(II) complexes tethered to dibenzo[c,h][1,6]naphthyridin-6-ones: synthesis and cytotoxicity in human cancer cell lines in vitro. Eur J Med Chem (2013) 0.78
Raltitrexed and oxaliplatin hepatic arterial infusion for advanced colorectal cancer: a retrospective study. Anticancer Drugs (2010) 0.78
Protective effect of intra-peritoneal epinephrine on postoperative renal function after cisplatin-based intra-peritoneal intra-operative chemotherapy. Eur J Obstet Gynecol Reprod Biol (2011) 0.78
Sirolimus, bevacizumab, 5-Fluorouracil and irinotecan for advanced colorectal cancer: a pilot study. World J Gastroenterol (2009) 0.78
Novel acylated triterpene glycosides from Muraltia heisteria. J Nat Prod (2002) 0.78
Randomised controlled trial of lipiodol transarterial chemoembolisation with or without amiodarone for unresectable hepatocellular carcinoma. Dig Liver Dis (2011) 0.77
Interest of intraoperative ultrasonography during pancreatectomy for metastatic renal cell carcinoma. Clin Res Hepatol Gastroenterol (2013) 0.77
Pilot study of transarterial chemoembolization with pirarubicin and amiodarone for unresectable hepatocellular carcinoma. Am J Clin Oncol (2009) 0.77
DNA-damaged polyploid cancer cells can reverse to diploidy: an ordered, but little understood, process of genomic reduction [with reference to the previous comments of Forer (2008) and Wheatley (2008a and b)]. Cell Biol Int (2009) 0.77
Retrospective analysis of survival benefits of chemotherapy for metastatic or non-resectable intrahepatic cholangiocarcinoma. Clin Res Hepatol Gastroenterol (2013) 0.77
Attempts to improve locoregional chemotherapy for the prevention of colonic cancer liver metastasis in the rat. Gastroenterol Clin Biol (2006) 0.77
Vandetanib for the treatment of advanced medullary thyroid cancer outside a clinical trial: results from a French cohort. Thyroid (2015) 0.77